tiprankstipranks
Advertisement
Advertisement

TENX Stock Latest News

Four new option listings on March 25th
The FlyFour new option listings on March 25th
11d ago
IPX
SUNC
Tenax Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Tenax Therapeutics files $300M mixed securities shelf
12d ago
TENX
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
PremiumThe Fly
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
19d ago
LI
AJG
Cantor starts Tenax at Overweight into Phase 3 readout
PremiumThe Fly
Cantor starts Tenax at Overweight into Phase 3 readout
19d ago
TENX
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
19d ago
TENX
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
PremiumThe FlyTenax Therapeutics price target raised to $34 from $25 at Guggenheim
20d ago
TENX
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
24d ago
TENX
Tenax Therapeutics reports Q4 EPS (38c), consensus (41c)
Premium
The Fly
Tenax Therapeutics reports Q4 EPS (38c), consensus (41c)
26d ago
TENX
Tenax Extends Phase 3 TNX-103 Study, Signaling Long-Term Bet on Pulmonary Hypertension Franchise
PremiumCompany Announcements
Tenax Extends Phase 3 TNX-103 Study, Signaling Long-Term Bet on Pulmonary Hypertension Franchise
1M ago
TENX
Tenax Therapeutics Updates Chief Medical Officer Agreement
PremiumCompany Announcements
Tenax Therapeutics Updates Chief Medical Officer Agreement
3M ago
8K
TENX
Optimistic Outlook on Tenax Therapeutics: Buy Rating Backed by Promising Clinical Developments
PremiumRatings
Optimistic Outlook on Tenax Therapeutics: Buy Rating Backed by Promising Clinical Developments
4M ago
TENX
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany Announcements
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
4M ago
TENX
Tenax Therapeutics reports result of prespecified blinded sample size assessment
PremiumThe FlyTenax Therapeutics reports result of prespecified blinded sample size assessment
4M ago
TENX
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
4M ago
TENX
Tenax Therapeutics to hold a conference call
Premium
The Fly
Tenax Therapeutics to hold a conference call
5M ago
TENX
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
PremiumCompany Announcements
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
5M ago
TENX
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
PremiumThe Fly
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
5M ago
TENX
TENX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TENX Earnings this Week: How Will it Perform?
5M ago
TENX
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany Announcements
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
5M ago
MEDP
TENX
Tenax Therapeutics management to meet with Piper Sandler
PremiumThe FlyTenax Therapeutics management to meet with Piper Sandler
6M ago
TENX
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
Premium
Ratings
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
7M ago
TENX
Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
Premium
The Fly
Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
7M ago
TENX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >